CYCC
Price:
$6.365
Market Cap:
$1.66M
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the clinical development stage, focused on discovering and advancing treatments for various cancers and other diseases involving abnormal cell growth. The company's active drug pipeline includes several promising candidates: Fadraciclib, a cyclin-dependent kinase (CDK) inhibitor, is presently undergoing Phase 1/2 clinical studies for solid tumors and is also being evaluated in combination with venetoclax for patients with chronic lymphocytic leukemia that has recurred or is resistant to previous therapies. CYC140, a polo-like kinase inhibitor, has progressed to Phase 1/2 clinical trials for the treatment of both advanced...[Read more]
Industry
Biotechnology
IPO Date
2004-03-16
Stock Exchange
NASDAQ
Ticker
CYCC
According to Cyclacel Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -51.20%. This represents a change of 229.96% compared to the average of -15.52% of the last 4 quarters.
The mean historical ROE of Cyclacel Pharmaceuticals, Inc. over the last ten years is -365.36%. The current -51.20% ROE has changed -85.99% with respect to the historical average. Over the past ten years (40 quarters), CYCC's ROE was at its highest in in the September 2024 quarter at 201.75%. The ROE was at its lowest in in the December 2023 quarter at -868.37%.
Average
-365.36%
Median
-48.34%
Minimum
-3715.82%
Maximum
515.73%
Discovering the peaks and valleys of Cyclacel Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.48%
Maximum Annual ROE = 515.73%
Minimum Annual Increase = -113.88%
Minimum Annual ROE = -3715.82%
| Year | ROE | Change |
|---|---|---|
| 2025 | -43.82% | -108.50% |
| 2024 | 515.73% | -113.88% |
| 2023 | -3715.82% | 3.48% |
| 2022 | -103.74% | 111.87% |
| 2021 | -48.97% | 92.85% |
| 2020 | -25.39% | -62.07% |
| 2019 | -66.94% | 40.27% |
| 2018 | -47.72% | 39.05% |
| 2017 | -34.32% | -58.46% |
| 2016 | -82.61% | 8.49% |
The current ROE of Cyclacel Pharmaceuticals, Inc. (CYCC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1081.30%
5-year avg
-679.32%
10-year avg
-365.36%
Cyclacel Pharmaceuticals, Inc.’s ROE is less than Scorpius Holdings, Inc. (0.01%), greater than Synaptogenix, Inc. (-120.29%), greater than Korro Bio, Inc. (-117.86%), greater than ObsEva S.A. (-146.39%), greater than Applied Molecular Transport Inc. (-111.78%), greater than Millendo Therapeutics, Inc. (-729.89%), greater than IMV Inc. (-495.17%), less than Apexigen, Inc. (48.27%), less than Gelesis Holdings, Inc. (31.43%), greater than ESSA Pharma Inc. (-16.63%),
| Company | ROE | Market cap |
|---|---|---|
| 0.01% | $13.63K | |
| -120.29% | $10.91M | |
| -117.86% | $129.29M | |
| -146.39% | $11.00M | |
| -111.78% | $11.01M | |
| -729.89% | $11.15M | |
| -495.17% | $23.42K | |
| 48.27% | $9.57M | |
| 31.43% | $11.63M | |
| -16.63% | $9.52M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyclacel Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cyclacel Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Cyclacel Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Cyclacel Pharmaceuticals, Inc. (CYCC)?
What is the highest ROE for Cyclacel Pharmaceuticals, Inc. (CYCC)?
What is the 3-year average ROE for Cyclacel Pharmaceuticals, Inc. (CYCC)?
What is the 5-year average ROE for Cyclacel Pharmaceuticals, Inc. (CYCC)?
How does the current ROE for Cyclacel Pharmaceuticals, Inc. (CYCC) compare to its historical average?